Home - Products - GPCR/G Protein - Antibacterial - HMPC

HMPC

CAS No. 128202-97-1

HMPC ( —— )

Catalog No. M11158 CAS No. 128202-97-1

HMPC is a novel bacteriostatic agent that shows bacteriostatic activity against S. aureus (MIC=4μg/ml) and rescues Caenorhabditis elegans from S. aureus infection.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
100MG	Get Quote	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

HMPC
Note

Research use only, not for human use.
Brief Description

HMPC is a novel bacteriostatic agent that shows bacteriostatic activity against S. aureus (MIC=4μg/ml) and rescues Caenorhabditis elegans from S. aureus infection.
Description

HMPC is a novel bacteriostatic agent that shows bacteriostatic activity against S. aureus (MIC=4μg/ml) and rescues Caenorhabditis elegans from S. aureus infection; acts via an unknown mechanism linked to the global transcriptional regulator MgrA.
Synonyms

——
Pathway

GPCR/G Protein
Target

Antibacterial
Recptor

Antibacterial
Research Area

——
Indication

——

Chemical Information

CAS Number

128202-97-1
Formula Weight

292.42
Molecular Formula

C14H16N2OS2
Purity

>98% (HPLC)
Solubility

——
SMILES

——
Chemical Name

propyl 5-hydroxy-3-methyl-1-phenyl-1H-pyrazole-4-carbodithioate

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Tatiana Johnston, et al. Scientific Reportsvolume 8, Article number: 7062 (2018). doi:10.1038/s41598-018-25571-w

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

ClpP inhibitor M21

ClpP inhibitor M21 is a noncompetitive inhibitor of ClpP with IC50 of 41.42 uM.
Linaroside

Linaroside exhibited 30% inhibition for antimycobacterial activity against Mycobacterium tuberculosis, strain H(37)Rv at 6.25 microg mL(-1) concentration.
CB-618

CB-618 (CB 238618) is a novel non-β-lactam β-lactamase inhibitor that potentiates meropenem MIC values against clinical Enterobacteriaceae isolates.

Sign In Join Free